ACS Medicinal Chemistry Letters,ACS MED CHEM LETT投稿指南及影响因子 — X-MOL学术平台

当前位置： X-MOL首页 › 最新SCI期刊查询及投稿分析系统 › ACS Medicinal Chemistry Letters杂志

ACS Medicinal Chemistry Letters

基本信息

期刊名称	ACS Medicinal Chemistry Letters ACS MED CHEM LETT
期刊ISSN	1948-5875
期刊官方网站	http://pubs.acs.org/journal/amclct
是否OA	否
出版商	American Chemical Society (ACS)
出版周期
始发年份	2010
年文章数	212
最新影响因子	4.2（2022） scijournal影响因子 greensci影响因子

中科院SCI期刊分区

大类学科	小类学科	Top	综述
医学2区	CHEMISTRY, MEDICINAL 药物化学2区	否	否

CiteScore

CiteScore排名			CiteScore	SJR	SNIP
学科	排名	百分位	3.51	1.202	0.905
Pharmacology, Toxicology and Pharmaceutics Drug Discovery	30 / 146	79%
Chemistry Organic Chemistry	35 / 177	80%
Biochemistry, Genetics and Molecular Biology Biochemistry	108 / 407	73%

补充信息

自引率	2.50%
H-index	41
SCI收录状况	Science Citation Index Expanded
官方审稿时间
网友分享审稿时间	数据统计中，敬请期待。
PubMed Central (PML)	http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1948-5875%5BISSN%5D

投稿指南

期刊投稿网址	https://acs.manuscriptcentral.com/acs
收稿范围	ACS Medicinal Chemistry Letters 乐于接收药物化学相关领域的稿件。该期刊涉及广泛的研究领域，包括化合物设计和优化、生物评估、药物递送、显像剂以及生物活性分子（小分子和大分子）药理学。具体领域包括但不限于以下内容：生物活性先导分子和药物（小分子和生物制剂）的鉴定、合成和优化药物发现过程中的新分子生物学表征用于生物活性分子、配体及其靶标等的鉴定或SAR分析的计算、化学信息和结构研究可广泛应用于药物化学的新方法，包括放射线生物化学源自合成和天然（植物及其他）的生物活性分子的发现技术药代动力学/药效学研究，探讨药物处置和反应的深层次机制药物遗传学和药物基因组学研究，用于增强药物设计以及将药物化学转化为临床药物药物代谢机制与代谢酶基因表达的调控与药物化学领域相关的化学专利
收录体裁	Letters Notes Technology Notes Innovations Viewpoints Letters to the Editor Patent Highlights
投稿指南	https://publish.acs.org/publish/author_guidelines?coden=amclct
投稿模板	https://pubs.acs.org/page/amclct/submission/amclct_templates.html
参考文献格式	https://publish.acs.org/publish/author_guidelines?coden=amclct#manuscript_preparation
编辑信息	Editor-in-Chief Dennis C. Liotta Department of Chemistry Emory University Editor’s Office: (404) 727-6602 E-mail: eic@medchemlett.acs.org Associate Editors Donna M. Huryn University of Pittsburgh E-mail: huryn@pitt.edu Bruce E. Maryanoff The Scripps Research Institute E-mail: bmaryano@scripps.edu Peter Wipf University of Pittsburgh E-mail: pwipf@pitt.edu Innovations Editors Stevan Djuric High Point University E-mail: djuric-office@medchemlett.acs.org Ya-Qiu Long Soochow University Medical College E-mail: long-office@medchemlett.acs.org Managing Editor Lorraine Clark Phone: (202) 872-6984 E-mail: l_clark@acs.org Patent Panelists Ahmed Abdel-Magid Therachem Research Medilab (India), Pvt. Ltd. Benjamin Blass Temple University School of Pharmacy Robert B. Kargbo Usona Institute Amy S. Ripka Lucy Therapeutics Gerard Rosse Dart Neuroscience Editorial Advisory Board Courtney C. Aldrich University of Minnesota Lucia Altucci Second University of Naples Jeffrey Aubé University of Kansas Maria Letizia Barreca University of Perugia Anthony G. M. Barrett Imperial College London Annette Beck-Sickinger University of Leipzig Brian S. J. Blagg University of Notre Dame Maria-Jesus Blanco Sage Therapeutics Carsten Bolm RWTH Aachen University Joanne J. Bronson Bristol-Myers Squibb Duane A. Burnett Arkuda Therapeutics Erick Carreira ETH Zürich Nick I. Carruthers Johnson & Johnson Margaret Chu-Moyer Amgen Andrew P. Combs Prelude Therapeutics Pat N. Confalone Dupont Maria Paola Costi University of Modena and Reggio Emilia Zoe Cournia Biomedical Research Foundation, Academy of Athens Huw Davies Emory University William Denny University of Auckland Ke Ding Chinese Academy of Sciences George Fleet University of Oxford Gunda I. Georg University of Minnesota William J. Greenlee MedChem Discovery Consulting, LLC Yvan Guindon Institut de recherches cliniques de Montréal Stephen Hanessian Université de Montréal Amy Hauck Newman National Institute of Drug Abuse-Intramural Research Program, NIH Jennifer M. Heemstra Emory University Piet Herdewijn KU Leuven Kenneth Jacobson National Institute of Diabetes & Digestive & Kidney Diseases Mukul R Jain Cadila Healthcare Ltd. Hualiang Jiang Chinese Academy of Sciences Jagath Reddy Junutula Cellerant Therapeutics, Inc. John A. Katzenellenbogen University of Illinois, Urbana-Champaign Beate Koksch Freie Universität Berlin Povl Krogsgaard-Larsen University of Copenhagen Mark J. Macielag Janssen Research & Development Neeraj Mahindroo University of Petroleum and Energy Studies Ruth Nussinov Leidos, National Cancer Institute, Frederick Yu Rao Tsinghua University Daniel Rauh Technische Universität Dortmund Allen B. Reitz Fox Chase Chemical Diversity Center, Inc. Charles H. Reynolds Gfree LLC Ralph A. Rivero GlaxoSmithKline Pharmaceuticals Bryan L. Roth University of North Carolina Silvia Schenone University of Genoa Mario Sechi University of Sassari Fatih Sen Dumlupinar University, Evliya Çelebi Campus Peter Senter Seattle Genetics, Inc. Richard B. Silverman Northwestern University Romano Silvestri Sapienza University of Rome Mikiko Sodeoka The Institute of Physical and Chemical Research (RIKEN) Michael Joseph Sofia Arbutus Biopharma, Inc. Claudiu T. Supuran University of Florence Kiyoshi Tomioka Kyoto University Shaomeng Wang University of Michigan Wendy B. Young Genentech Nurulain T. Zaveri Astraea Therapeutics Zhong-Yin Zhang Indiana University School of Medicine Ming-Ming Zhou Mount Sinai School of Medicine Early Career Board Ashley M. Adams AbbVie Ryan A. Altman The University of Kansas Annalaura Brai Lead Discovery Siena s.r.l Jennifer E. Golden University of Wisconsin-Madison Giuseppe La Regina Sapienza Universita' di Roma Zhengqiu Li Jinan University Terry W. Moore University of Illinois at Chicago William C.K. Pomerantz University of Minnesota Naomi S. Rajapaksa Genentech, Inc.

我要分享 (欢迎您来完善期刊的资料，分享您的实际投稿经验)

研究领域：
投稿录用情况：		审稿时间：个月返回审稿结果
本次投稿点评：
	提交

客服邮箱：service@x-mol.com
官方微信：X-molTeam2
邮编：100098
地址：北京市海淀区知春路56号中航科技大厦

bug